AKAP12 and squamous cell carcinoma: We extended the studies from HEK293 cells to human epidermoid carcinoma A431 cells, again probing if overexpression of AKAP12 would impact the AKAP5-mediated Erk1/2 activation in response to β-adrenergic agonist.